Dr. Marcus uses case examples to review best practices in screening for cervical cancer, gonorrhea, chlamydia and HPV in young women.
In this activity, Dr. Batur from The Cleveland Clinic describes how to identify and evaluate risks associated with hormonal and oral contraceptives. Three different cases demonstrate how to assess VTE and cardiovascular risk factors and the best approach to take when prescribing contraceptives to treat premenstrual migraines in patients on contraceptives.
In this Clinical Coffee Break, Dr. Christine Curry answers some common questions about infection screening and antibiotic use in women with IUDs.
In this brief activity, Dr. Jane Sillman discusses some changing paradigms in the management of hot flushes and other vasomotor symptoms in menopausal women. She addresses both pharmacological and non-pharmacological strategies to manage these conditions in patients.
Learn how to prescribe the correct contraceptive to a patient after assessing their previous medical history. In this activity, Dr. Batur reviews the available contraception methods including the newest options on the market. This activity also discusses practice recommendations for contraceptive use along with safety concerns associated with each class of contraceptives.
Moderate to severe hot flashes affect nearly half of women during the menopause transition. At this time the risk of major depression is also heightened. Dr. Janet Pregler, Director of Iris Cantor-UCLA Women’s Health Center, will discuss the risks and benefits of using hormonal therapy as well as its alternatives to treat the symptoms of menopause in women during transition.
Dr. Johnson from the David Geffen School of Medicine at UCLA will review the significance and treatment options of Coronary Artery Disease (CAD) in women. He will discuss the differences in clinical presentation by gender, symptoms and age, along with appropriate diagnostic approaches. Appropriate treatment options and management strategies for women with CAD in accordance with the latest guidelines will also be discussed.
Vaginitis is one of the most common gynecologic problems seen in ambulatory practice. Its differential diagnosis includes not only a vaginal infection but also cervicitis, a physiologic discharge, atrophic vaginitis, and iatrogenic vaginitis. With the help of case studies, Dr. Quan, Professor of Clinical Family Medicine at the David Geffen School of Medicine at UCLA will demonstrate how a precise diagnosis can be achieved with a careful history, focused examination, and skilled use of the office laboratory. He will also review the various therapies that can be prescribed once an accurate diagnosis is made and their effectiveness in treating vaginitis.
In this activity, Dr. Crandall will review the safety and efficacy of new selective estrogren receptor modulators (SERMs) approved for menopause hormone therapy. She will also discuss data from new studies on oral hormone replacement therapy and potential systemic effects of available vaginal estrogen medications.
Long acting reversible contraception (LARC) provides patients with an excellent way to prevent pregnancy. There are many benefits to these methods, including limited patient responsibility for adherence, high efficacy at pregnancy prevention and long duration of action. In addition, there are many non-contraceptive indications for the use of LARC that can help manage conditions seen by primary care physicians. Increasingly, national organizations are recommending LARC as first line contraception for adolescents and adults. Identification of candidates for LARC, appropriate counseling and timely referrals can help patients obtain contraception and decrease unintended pregnancies.
This session will present an overview of the common causes of chronic pelvic pain. The link between chronic pelvic pain and sexual dysfunction will be discussed. A classification of female sexual dysfunction will be presented and participants will leave with an approach to female patients who present with sexual dysfunction.
Primary care physicians form the core of the follow-up care for breast cancer survivors. In this activity, the expert faculty will discuss the recommended surveillance for late recurrence and secondary primary malignancies. You will learn to manage patient anxiety and other psychosocial issues in this population.